P&K Skin Research Center Co.,Ltd.: debt-to-equity, ROE and more
KOSDAQ, Legal name P&K Skin Research Center Co.,Ltd.
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 7.5%
- Equity ratio
- 93.0%
- ROE
- 5.7%
- Op. margin
- 17.3%
- Rev. growth
- 27.7%
- Interest coverage
- n/a
Condition flags
- Operating profit for 5 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
| Fiscal year | Cash dividend per share | Payout ratio |
|---|---|---|
| 2025 | ₩50 | 27.0% |
| 2024 | ₩40 | 16.8% |
| 2023 | ₩30 | 14.9% |
Cash dividends for 3 straight years (only the 3 years OpenDART returns).
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 separate | 6.4% | 94.0% | 11.6% | 36.9% | n/a |
| FY2022 separate | 5.3% | 95.0% | 10.1% | 31.4% | 2.7% |
| FY2023 consolidated | 4.3% | 95.9% | 6.3% | 9.3% | -17.3% |
| FY2024 consolidated | 6.7% | 93.7% | 7.4% | 14.5% | 20.2% |
| FY2025 consolidated | 7.5% | 93.0% | 5.7% | 17.3% | 27.7% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩17.5B | ₩18.0B | ₩14.8B | ₩17.8B | ₩22.8B |
| Operating profit | ₩6.5B | ₩5.6B | ₩1.4B | ₩2.6B | ₩3.9B |
| Pre-tax income | ₩8.5B | ₩8.2B | ₩5.4B | ₩6.8B | ₩5.8B |
| Net income | ₩7.3B | ₩7.1B | ₩4.7B | ₩5.7B | ₩4.6B |
| Total assets | ₩67.1B | ₩74.5B | ₩77.4B | ₩82.0B | ₩86.5B |
| Total liabilities | ₩4.0B | ₩3.7B | ₩3.2B | ₩5.2B | ₩6.0B |
| Total equity | ₩63.1B | ₩70.8B | ₩74.2B | ₩76.9B | ₩80.5B |
| Paid-in capital | ₩3.8B | ₩15.0B | ₩15.0B | ₩15.0B | ₩15.0B |
| Debt/equity (source value) | 6.4% | 5.3% | 4.3% | 6.7% | 7.5% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 2010-10-07
- Listed
- 20/09/09
- Employees
- 121
- Auditor
- 한영회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1101114445725
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 피엔케이피부임상연구센타Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.